A new $100-million program aims to improve the diversity of participants in U.S. clinical trials with the ultimate goal of achieving…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
Myeloma UK is calling for more data transparency in government efforts to safeguard myeloma patients during the COVID-19…
The cast of the hit sitcom “Everybody Loves Raymond” reunited online to honor former co-star Peter Boyle for…
Stand Up To Cancer (SU2C) has awarded the 2020 SU2C Sharp Tank Award to Catherine Marinac, PhD, to…
The navigation platform HealthTree has added a feature that enables people with myeloma to communicate with other patients on…
Throughout September for Blood Cancer Awareness Month, the Leukemia & Lymphoma Society (LLS) is asking the public to join…
The online portal HealthTree has opened a free and online patient resource connecting multiple myeloma experts from around the…
Over some four weeks, 1,066 people with multiple myeloma took part in a survey sponsored by HealthTree to better understand how…
With an emphasis on the ability of patients and caregivers to adapt to challenges, the International Myeloma Foundation (IMF)…
Takeda and Snow Companies won one of the top prizes in PM360’s annual Pharma Choice Awards…